Skip to main content

Table 2 Number and percentage of mutations detected by methods

From: A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas

Methods

Mutations/samples

%

Mutations/samples

%

Direct sequencing

6/131

4.5

6/116

5.2

Pyrosequencing

10/131

7.6

10/116

8.7

HRM

-

-

15/116

13.1

TheraScreen DxS

20/131

15.2

17/116

14.6

K-ras StripAssay

26/131

19.8

24/116

20.7

  1. To allow comparison with HRM, results are provided not only for 131 but also for 116 samples.